| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |